Baseline immune activation as a risk factor for the onset of depression during interferon-alpha treatment. [electronic resource]
Producer: 20060811Description: 77-9 p. digitalISSN:- 0006-3223
- Adult
- Analysis of Variance
- Antiviral Agents -- adverse effects
- Cytokines -- metabolism
- Depressive Disorder, Major -- chemically induced
- Female
- Hepatitis C, Chronic -- drug therapy
- Humans
- Interferon-alpha -- adverse effects
- Interleukin-10 -- immunology
- Interleukin-6 -- immunology
- Male
- Middle Aged
- Receptors, Interleukin-2 -- immunology
- Risk Factors
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.